Skip to main content
. 2024 Apr 5;103(14):e37589. doi: 10.1097/MD.0000000000037589

Table 7.

Interleukin 1 in 2 groups of patients β.

Control group (n = 101) Experimental group—high concentration alkaline water (n = 100) Experimental group—medium concentration alkaline water (n = 100) Experimental group—low concentration alkaline water (n = 96)
H

P
Before treatment 56.97 (50.93, 62.09) 56.26 (51.62, 62.23) 55.62 (50.63, 59.38) 57.28 (49.90, 60.41) 25.97 .00
3 mo after treatment 55.69 (50.04, 62.59) 51.52 (46.09, 56.73) 53.34 (48.55, 58.51) 49.87 (45.69, 55.02) 182.26 2.86e−39
6 mo after treatment 55.58 (51.22, 60.66) 49.75 (43.81, 54.05) 47.94 (41.26, 52.04) 45.10 (39.42, 50.32) 273.67 4.96e−59
12 mo after treatment 54.00 (49.91, 59.95) 47.10 (41.40, 52.06) 45.10 (41.16, 50.24) 39.21 (34.63, 44.23) 328.65 6.25e−71

Comparison before and after treatment (Person) M(P25, P75) (pg/mL).